Latest Announcements

Vimta Labs Limited has informed the Exchange about the schedule of an Analyst/Investor Conference call, post announcement of Q2 Financial Results FY 2026-27, to be held on 30th October 2026.

Vineet Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, stating that there are no deviations or variations in the utilization of the proceeds of the Rights Issue of the Company during the quarter ended on June 30, 2026.

Styrenix Performance Materials Limited has scheduled an earnings call to discuss its unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, on October 29, 2026.

P N Gadgil Jewellers Limited has informed the Exchange about the schedule of an Investors/Analysts Conference Call to discuss the Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Vidhi Specialty Food Ingredients Limited has made available the audio recording of its Q2 & H1 FY27 earnings call on the financial results for the second quarter and half year ended September 30, 2026, on its website.

DCM Shriram Limited has released its investor presentation for Q2 FY 2027, highlighting its segment-wise performance, revenue and PBDIT drivers, and management's message. The company's Chemicals business delivered a reasonable performance despite a volatile global environment, while the Sugar and Ethanol businesses are navigating a shifting landscape due to government tenders restricting certain sugarcane-based feedstocks.

ESAF Small Finance Bank Limited has informed the Exchange regarding allotment of equity shares pursuant to exercise of ESOP under ESAF Employee Stock Option Scheme 2019.

Tarmat Limited has informed the Exchange with copy of minutes of 41st Annual General Meeting held on September 30, 2026. The meeting was conducted through video conference, and the minutes were circulated to all members in compliance with relevant circulars of the Ministry of Corporate Affairs.

State Bank of India has informed the Exchange about a meeting of the Central Board to consider the financial results for the quarter and half year ended 30.09.2026. An Analyst Meet will be conducted on 3rd November 2026 at 5.15 PM post declaration of Q2FY27 Results.

Creative Newtech Limited has informed the Exchange about an upcoming Earnings Conference Call to discuss the financial results for the quarter and half year ended 30th September 2026, scheduled to be held on 29th October 2026.

Music Broadcast Limited has informed the Exchange about Investor Presentation on Un-audited Financial Results for second quarter and half year ended September 30, 2026.

DCM Shriram Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting a 22% revenue growth in Q2 FY27 at ₹3,977 crore and an interim dividend of 200%.

Excelsoft Technologies Limited has informed the Exchange about the schedule of its Earning Conference Call for the 2nd Quarter (Q2) ended September 30, 2026, to be held on November 06, 2026.

RIR Power Electronics Limited has submitted its financial results for the period ended September 30, 2026.

Huhtamaki India Limited has informed the Exchange about the schedule of a meet to discuss unaudited Financial Results for the 3rd quarter ended on September 30, 2026.

Venus Remedies Limited has submitted its unaudited financial results for the quarter ended September 30, 2026, with the company's management represented that the pending share application money of INR 2,859.72 Lakhs for Venus Pharma GmbH is strategic in nature and will be recovered in due course.

KRBL Limited has scheduled a conference call for analysts and investors to discuss the Q2 FY27 results, which will be announced on Monday, November 2, 2026.

Everest Industries Limited has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee. The company has enclosed the limited review reports and unaudited financial results with the announcement.

Vineet Laboratories Limited has submitted its financial results for the quarter ended June 30, 2026, with the company's net income from operations at ₹1,050.12 lakh, total income at ₹1,050.12 lakh, and total expenses at ₹971.56 lakh. The company's profit before exceptional items and tax is ₹856 lakh, and the tax expense is ₹7286 lakh. The company's paid-up equity share capital is ₹192.063 lakh, and the earnings per equity share are ₹0.94.

Sahajanand Medical Technologies Limited has informed the Exchange about Schedule of Earnings Conference call to discuss the Q2 & H1FY27 financial results to be held on Thursday, November 05, 2026 at 06:30 p.m. (IST).